Impact of a Loading Dose of Caspofungin on Pharmacokinetic and Pharmacodynamic Parameters Target Achievements for Severe Candida Infections in ICU Patients

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 28 Sep 2020

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

12 Sep 2020 Results assessing impact of a high loading dose of caspofungin on the pharmacokinetic of CAS and the pharmacokinetic-pharmacodynamic (PK-PD) target attainment in intensive care units (ICU) patients, published in the Antimicrobial Agents and Chemotherapy.
03 Apr 2017 Status changed from not yet recruiting to completed.
13 Apr 2015 New trial record

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com